After carefully analyzing the electronic health records (EHRs) of 11,000 patients, investigators at the Icahn School of Medicine at Mount Sinai have discovered three potential new subtypes of type 2 diabetes.
The discovery, led by Joel Dudley, PhD, Director of Biomedical Informatics at the Icahn School of Medicine, highlights the power of new technology and the promise of precision medicine, as the Mount Sinai Health System ushers in the use of Big Data in discovering, treating, and preventing disease. The results of the study were published in Science Translational Medicine in October, 2015. Read more
Fred Lin, MD, Chief of the Division of Sleep Surgery at the Mount Sinai Health System, left, and Boris Chernobilsky, MD, Director of the Division of Sleep Surgery at Mount Sinai Beth Israel, are pioneering new surgery for sleep apnea.
Physicians at the Mount Sinai Health System are among the first in New York State to offer a promising new surgical treatment for people with moderate-to-severe obstructive sleep apnea, a common disorder characterized by the recurrent narrowing and closing of a person’s upper airway during sleep. Moderate-to-severe sleep apnea—defined as 15 or more episodes of disturbed airflow per hour—is often associated with excessive daytime sleepiness and an increased risk for diabetes and heart disease. Read more
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, published in Nature Medicine.
Diabetes results from too few insulin-producing “beta cells” in the pancreas secreting too little insulin, the hormone required to keep blood sugar levels in the normal range. In a groundbreaking Mount Sinai study, researchers found that harmine drove the sustained division and multiplication of adult human beta cells in culture, a feat that had eluded the field for years. In addition, harmine treatment tripled the number of beta cells and led to better control of blood sugar in three groups of mice engineered to mimic human diabetes. Read more
Andrew Stewart, MD, the Irene and Dr. Arthur M. Fishberg Professor of Medicine and Director of Mount Sinai’s Diabetes, Obesity and Metabolism Institute led a team of scientists who discovered a novel mechanism that regulates the replication of insulin-producing beta cells in the pancreas. Their findings provided novel working models describing the control of cell cycle progression in the human beta cell. These discoveries offer new insights into possible therapeutic approaches to stimulate the regeneration of pancreatic beta cells in patients with Type 1 and Type 2 diabetes. Read more
Hundreds of Mount Sinai Health System employees laced up their sneakers and participated in several 30-minute, lunchtime walks in their hospital campus communities on Wednesday, April 1, for National Walking Day, to raise awareness of the health benefits of walking for cardiovascular health. Beth Oliver, DNP, RN, Vice President of Cardiac Services for the Mount Sinai Health System, set the tone for the day, saying, “Mount Sinai is committed to teaming up to get active and make strides against cardiovascular diseases. A simple 30-minute brisk walk each day can significantly impact and improve heart health and longevity.” Walking, she says, can help individuals lower risk of heart attacks and strokes, maintain normal blood pressure, reduce cholesterol, and prevent diabetes and obesity.
Elizabeth Peralta, a Laboratory Technician at The Mount Sinai Hospital, lost 55 pounds in five months and reversed her diagnosis of type 2 diabetes with help from The Diabetes Alliance at the Mount Sinai Health System. The Diabetes Alliance offers Mount Sinai staff and patients personalized diabetes education, nutrition, and counseling and support to achieve their health and wellness goals.
The quick turnaround for Ms. Peralta started in July, after a routine physical with her internist, Laurie Edelman, MD, revealed that her blood sugar level had significantly increased over the prior year, resulting in a diagnosis of uncontrolled type 2 diabetes. Dr. Edelman is an Associate Professor in the Division of General Internal Medicine at Icahn School of Medicine at Mount Sinai. Read more
In recognition of Diabetes Awareness Month in November, the Mount Sinai Diabetes Center hosted an educational event for patients, staff, and the community in the Guggenheim Atrium on how to prevent and control diabetes. It included “Viva Fitness” demonstrations and tastings by the Food and Nutrition Department.
There are more than 23 million people in the United States, including 1.6 million in New York State, who have type 2 diabetes, which occurs when the body is resistant to the action of insulin, a hormone produced by the pancreas to lower the blood sugar. Type 2 diabetes, which is often associated with obesity, can result in kidney failure, limb amputations, blindness, heart disease, and stroke when blood sugar levels are uncontrolled.
“Many of these individuals who are living with type 2 diabetes and obesity are trying tirelessly to manage their diabetes and blood sugar, but without success,” says Aida Saliby, MD, of the Department of Endocrinology at Beth Israel Medical Center. “They do not respond fully to diet and lifestyle modifications, or they become resistant to the effects of oral medications, requiring additional treatments to manage their disease. Given the severe and growing diabetes epidemic, there is a substantial need to develop new, more effective therapies,” she says.
Mount Sinai physicians, nurses, and diabetes educators participated in the American Diabetes Association (ADA) Diabetes Expo on Saturday, March 9, at the Jacob K. Javits Center. The Mount Sinai team of more than 70 volunteers provided free screenings for blood pressure, weight, blood sugar, and cholesterol, as well as eye exams, to approximately 500 individuals. Physicians were on site to interpret the screening results and discuss how participants could take better control of their diabetes.
Two years before seeking help from physicians at The Mount Sinai Medical Center, Rosemary McGinn, 53, was diagnosed with hypoglycemia. She went everywhere with an arsenal of snacks and juices that she ingested frequently to keep her blood sugar from dropping.
“When my sugar would suddenly crash, it was like I was drunk,” she says. “I would become very combative, not knowing what I was saying, and sway back and forth.”